November 5, 2026 Bonus Content: Cigna Reports While CVS Burns. Here Is What Changes. A note from our friends at…
Microchip’s Q2 Report Tonight: What the Channel Inventory Number Actually Decides
With memory and AI names dragging the SOX down, tonight's MCHP call is the clearest read on where the analog…
Novo Nordisk Just Proved the Price War Story Was Wrong
A beat on every line and a third guidance raise in 2026 show the Wegovy pill is filling the gap…
Novo Nordisk Beats Estimates. Wegovy Pill Is the Reason.
The company everyone had written off as losing the obesity drug war just delivered its cleanest quarter in over a…
Wall Street bracing for $60 trillion revaluation in just…
November 4, 2026 Bonus Content: Arista Networks Beat Guidance by $358 Million. The 2027 Orders Tell the Bigger Story. A…
What’s Elon building now?
November 4, 2026 Bonus Content: Robinhood’s Record Options Volume Hid a Profit Problem A note from our friends at Paradigm…
Novo Nordisk Just Beat Again. The Stock Still Trades at 10x Earnings.
Wegovy pill sales hit DKK 5.394B today. The valuation gap is hard to ignore.
DRAM Has Doubled. Is Micron the Buy, or the Warning Sign?
Memory is now rationed by contract, Korean producers plan steep PC output cuts, and Micron's financials look extraordinary. That combination…
Lumentum’s Premium Vanished as Marvell Stock Fell
When Marvell announced its definitive agreement to acquire Lumentum on Monday, the press release led with a 23.9% premium. By…
Elon to replace the dollar?
November 3, 2026 Bonus Content: Palantir Beat Earnings. One Contract Number Ended the Party. A note from our friends at…